|
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Blood Test Promises to Find Single Cancer Cell Among Millions of Normal Ones"There's a lot of potential here, and that's why there's a lot of excitement." (Raritan, NJ)—Several news agencies this week have reported on an AP story about a "revolutionary" blood test that can spot a single cancer cell among millions of healthy ones. Since four large cancer centers will be using it in studies, and Johnson & Johnson has decided to bring it to the market, it signals great hope for early detection of the disease. "Measuring CTCs in metastatic breast cancer patients provides oncologists with an additional tool to help us better monitor patient outcomes," said one of the lead authors, Dr. Massimo Cristofanilli, associate professor in the Department of Breast Medical Oncology at The University of Texas M. D. Anderson Cancer Center. "The CellSearch(R) CTC test provides an early indication about patients' disease progression and overall survival." The CellSearch(R) test works by using antibodies that are joined to microscopic iron particles, called ferrofluid. These antibody/ferrofluid combinations attach very specifically to CTCs. Powerful magnets then draw the CTCs out of the blood sample and they are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs. 
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Other Recent Articles from Breaking Christian News 250 Reasons Why We Love America Stories of Heroism and Miracles from the Devastation in Venezuela, Shared on Social Media Enemies Within: The Threat of Communism to America Man Taken into Custody in Somalia for Role in Huge MN Fraud Scheme Supreme Court Decision Sparks Urgent Calls to Pass SAVE America Act Supreme Court Upholds Birthright Citizenship in Blow to Trump Immigration Enforcement Supreme Court Rules on State Laws Excluding Men From Women's Sports America 250: Freedom Trucks Travel across US Celebrating American History Lowest Gas Prices Are in States with Republican Governors, Legislatures: Report MLB's Texas Rangers Shun 'Pride Night,' Host 'Faith and Family Night' Instead Resolution to Preserve Daughters of the American Revolution for Women Only Is Defeated Texas Institutes Bible Passages into Its Public School Reading List Justice Alito Torches SCOTUS Ruling in Mail-in Ballot Case, Warns of Voter Fraud SCOTUS Rules 5-4 to Permit Counting of Mail-In Ballots that Arrive AFTER Election Day America's Semiquincentennial Begins: Trump Launches Massive National Mall Expo Woman Removed from Detroit Tigers Game for Wearing 'Jesus Over Pride' Shirt Netherlands Does the Unthinkable: Euthanize a Young Child |
Subscribe to
|
Notes excerpts from a PR Newswire release about the test, coined the CellSearch system: Measuring the change in circulating tumor cell (CTC) count can accurately predict the prognosis and survival in patients with metastatic breast cancer (MBC), according to a newly published report in the July 10, 2010 issue of the Journal of Clinical Oncology. The CellSearch(R) System is the first 510(k) diagnostic test used to automate the capture and detection of CTCs, tumor cells that have detached from solid tumors and entered the patient's blood. (Photo by: 
All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.
Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved
Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.
| Home | Store | Subscribe | Facebook | Article Archive |